The NeuroVision treatment is a non-surgical technology for improving your vision by enhancing the processing power in the brain. This non-invasive treatment is based on an innovative technology that has undergone 20 years of research. It is suitable for you if your age is 9 years and above and have shortsightedness (myopia) of less than -2.00(200 degrees) or lazy eyes (amblyopia).

Myopia or short-sightedness is the most prevalent eye disorder in Malaysia. This trend is seen in many other countries in the Asia-Pacific, such as Singapore, Hong Kong, Taiwan and Japan where as high as 80 per cent of young adult population is myopic. NeuroVision’s launch of its first treatment centre in Malaysia at iLaser Centre provides the opportunity for the Malaysian community with an increasing rate of myopia to be among the first in the world to benefit from its technology.

The success rate of the NeuroVision treatment is encouraging, with over 80 per cent of the participants in its clinical trials, conducted in the United States, Singapore and Israel, showing visual improvement. The technology has minimal risk and has received regulatory approval from the United States Federal Drug Administration (FDA) and the European Union’s CE Mark. In achieving the approval of these globally respected regulatory bodies, the NeuroVision treatment demonstrated safety in treatment, reliability in results and validity of its technology.

iLaser Centre will start offering NeuroVision to patients in November 2004. Once again, we are proud to be a pioneer in offering state of the art treatment options. Besides being the 1st certified NeuroVision centre in Malaysia, iLaser Centre is also proud to have the first Certified NeuroVision treatment administrator in this country.

For further information, visit www.neuro-vision.com.

Quick Downloads

NeuroVision Myopia brochure - pdf

NeuroVisionAmblyopia brochure - pdf